UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045159
Receipt number R000051589
Scientific Title Estimation of Clinical Features and Outcomes of Effusive Constrictive Pericarditis in Patients Presented with Cardiac Tamponade
Date of disclosure of the study information 2021/08/15
Last modified on 2021/12/18 12:27:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Estimation of Clinical Features and Outcomes of Effusive Constrictive Pericarditis in Patients Presented with Cardiac Tamponade

Acronym

ELUCIDATE-ECP

Scientific Title

Estimation of Clinical Features and Outcomes of Effusive Constrictive Pericarditis in Patients Presented with Cardiac Tamponade

Scientific Title:Acronym

ELUCIDATE-ECP

Region

Japan


Condition

Condition

Effusive constrictive pericarditis

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the incidence rate and prognosis of effusive constrictive pericarditis (ECP) in patients with pericardial effusion. In addition, we aimed to identify optical diagnostic method of ECP.

Basic objectives2

Others

Basic objectives -Others

To evaluate the incidence rate and prognosis of effusive constrictive pericarditis (ECP) in patients with pericardial effusion. In addition, we aimed to identify optical diagnostic method of ECP.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Incidence of effusive constrictive pericarditis

Key secondary outcomes

1)recurrence of pericardial effusion
2)surgical pericardial removal
3)1-year all-cause mortality, 1-year cardiovascular death, 1-year heart failure hospitalization, and cardiovascular event during one year
4)composite outcomes 1-year all-cause mortality and heart failure hospitalization
5)cardiac biomarker changes (BNP, NT-proBNP, and troponin)
6)renal function changes


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients undergo (1) pericardiocentesis for pericardial effusion and (2) right heart catheterization to evaluate pre- and post-pericardiocentesis hemodynamics.

Key exclusion criteria

Patients who refused with participation in this study.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Shingo
Middle name
Last name Matsumoto

Organization

Toho University Facalty of Medicine

Division name

Department of Cardiology

Zip code

1438541

Address

6-11-1 Omorinishi, Ota-ku, Tokyo 143-8541, Japan

TEL

03-3762-4151

Email

shingomatsumoto0606@gmail.com


Public contact

Name of contact person

1st name Wataru
Middle name
Last name Fujimoto

Organization

Awaji medical center

Division name

Cardiology

Zip code

6560021

Address

137-1-1 Shioya, Sumoto

TEL

+81799221200

Homepage URL


Email

watarutaru_328@yahoo.co.jp


Sponsor or person

Institute

Awaji medical center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Awaji medical center

Address

1-1-137 Shioya, Sumoto

Tel

+81799221200

Email

Miki_Tsukahara@pref.hyogo.lg.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

淡路医療センター(兵庫県)、東邦大学医療センター大森病院(東京都)、岩手医科大学附属病院(岩手県)、群馬大学医学部附属病院(群馬県)、手稲渓仁会病院(北海道)、弘前大学大学院(青森県)、聖隷浜松病院(静岡県)、久留米大学病院(福岡県)、JCHO九州病院(福岡県)、一宮市立市民病院(愛知県)、姫路循環器病センター(兵庫県)、北里大学病院(東京都)、東海大学付属病院(神奈川県)、東京女子医科大学東医療センター(東京都)、虎ノ門病院(東京都)、獨協医科大学(栃木県)、大阪市立大学(大阪府)、帝京大学(東京都)、大阪医科薬科大学(大阪府)、京都桂病院(京都府)、大阪急性期・総合医療センター(大阪府)


Other administrative information

Date of disclosure of the study information

2021 Year 08 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 05 Month 01 Day

Date of IRB

2021 Year 05 Month 20 Day

Anticipated trial start date

2021 Year 06 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Right heart catheterization, echocardiography, and so on before and after pericardiocentesis


Management information

Registered date

2021 Year 08 Month 15 Day

Last modified on

2021 Year 12 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051589


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name